Advertisement

Hypofractionated radiation therapy for breast cancer: long-term results in a series of 85 patients

Abstract

Purpose

Whole-breast irradiation after conservative surgery is the standard treatment for early breast cancer. The purpose of this study is to report the late toxicity, cosmetic result, and disease control in a group of patients treated with hypofractionated radiotherapy (RT) comparing results with retrospective data of a control group who underwent conventional RT.

Methods

From 2006 to 2008, 85 patients were treated with hypofractionated schedule to dose of 45 Gy, 2.25 Gy/fr, followed by a boost. We evaluated late toxicity, cosmetic result, and disease control. The data were compared to a control group of 70 patients who underwent conventional RT before 2006.

Results

At 8 years of follow-up, the cumulative incidence of late skin toxicity was 6.2 in the hypofractionated RT group and 7.5 in the standard RT group (p = 0.94). The cumulative incidence of late subcutaneous tissue toxicity was 11.6 in the hypofractionated RT group and 18.7 in the standard RT group (p = 0.23). Cosmetic outcome was rated as excellent or good in 84/85 patients of the hypofractionated RT group and in 68/70 patients of the conventional RT group (p = 0.7). No statistically significant differences were found in terms of local control (p = 0.05), disease-free survival (p = 0.06), or overall survival (p = 0.17) between the 2 groups.

Conclusions

The present analysis, focused on long-term effects, disease control, and survival, confirms, in a daily practice setting, the low incidence of skin atrophy and fibrosis, the satisfactory cosmetic outcome, and the high grade of local and distant disease control with hypofractionated schedule.

Tumori 2016; 102(4): 398 - 403

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.5301/tj.5000511

Authors

Letizia Deantonio, Salvatore Cozzi, Sara Tunesi, Marco Brambilla, Laura Masini, Carla Pisani, Giuseppina Gambaro, Corrado Magnani, Marco Krengli

Article History

Disclosures

Financial support: Supported by the “Lega Italiana per la lotta contro i tumori LILT (Italian league against cancer),” Section of Vercelli, Italy.
Conflict of interest: None of the authors has conflict of interest with this submission.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  •  Radiotherapy, University Hospital “Maggiore della Carità,” Novara - Italy
  •  Department of Translational Medicine, University of “Piemonte Orientale,” Novara - Italy
  •  Biostatistics and Clinical Epidemiology, University of “Piemonte Orientale,” Novara - Italy
  •  Medical Physics, University Hospital “Maggiore della Carità,” Novara - Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.